Country: Afrika t’Isfel
Lingwa: Ingliż
Sors: South African Health Products Regulatory Authority (SAHPRA)
Sad-otc
LAXENE TABLETS SCHEDULING STATUS: Not scheduled. PROPRIETARY NAME (and dosage form): LAXENE TABLETS COMPOSITION: Yellow Phenolphthalein 120 mg PRESERVATIVE: Sodium Benzoate 0,03 % m/m PHARMACOLOGICAL CLASSIFICATION: A 11.5 Laxatives. PHARMACOLOGICAL ACTION: Phenolphthalein stimulated the bowel causing peristalsis and laxative action. INDICATIONS: Relief of constipation. CONTRA-INDICATIONS: Nausea and vomiting. Pregnancy. Phenolphthalein should not be taken by patients with symptoms of appendicitis, intestinal obstruction or abdominal pain of unknown cause, or with known sensitivity to phenolphthalein. Should prolonged use of laxatives become necessary, consult your doctor. WARNING: Should not be taken when patient is pregnant. If a skin rash appears or if a patient is known to be sensitive in any other regard to phenolphthalein this medicine should be discontinued immediately, and this or any other preparation containing phenolphthalein should not be used in future. Continued usage in these circumstances could lead to toxic epidermal necrolysis which may be life threatening. If a sudden change in bowel habits that persist over a period of two weeks have been noticed consult your doctor before using a laxative. If the recommended use of this product for 1 week has had no effect, discontinue and consult your doctor. Frequent or prolonged use of this preparation may result in dependence on laxatives. DOSAGE AND DIRECTIONS FOR USE: Do not exceed stated dose. ADULT DOSE: One tablet with water at night. This preparation is not recommended for children. SIDE EFFECTS AND SPECIAL PRECAUTIONS: The constant use of purgatives may decrease the sensitivity of the intestinal mucous membranes. The use of purgatives may be associated with abdominal c Aqra d-dokument sħiħ